SCHEMBL7319481

SCHEMBL7319481

Nc1c(Cl)cc(C(=O)O)c2oc3c(c12)CCCC3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.36
▸ NPY1R P25929 1/20 0.34
▸ NPY2R P49146 1/20 0.34
▸ POLB P06746 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ HTT P42858 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ GPR35 Q9HC97 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ SLC16A3 O15427 1/20 0.32
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7317925 0.88 TTR (0.39) KMT2ANPY1RNPY2RPOLBHTT
SCHEMBL7317931 0.76 KDM4E (0.35) KMT2APOLBHPGDCASP1HSD17B10
SCHEMBL7334850 0.72 TSHR (0.42) KMT2APOLBTSHRHTTUSP2
SCHEMBL7393097 0.72 TTR (0.38) KMT2APOLBTSHRUSP2HPGD
SCHEMBL7333211 0.70 HTR4 (0.46) ACHE
SCHEMBL7312519 0.69 TTR (0.48) KMT2APOLBTSHRHTTUSP2
SCHEMBL5316552 0.69 HTR4 (0.47) —
SCHEMBL7304993 0.67 KDM4E (0.39) KMT2APOLBTSHRUSP2HPGD
SCHEMBL10593730 0.66 CYP1A2 (0.41) KMT2APOLBHTTHPGDMAPT
SCHEMBL30888620 0.66 TSHR (0.41) KMT2APOLBTSHRHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246942-A Central nervous system, anti-emetic and gastric prokinetic activity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1993-09-21 — — US disclosed
EP-0494140-A4 DIBENZOFURANCARBOXAMIDES — 1992-09-02 — — EP disclosed
EP-0494140-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1992-07-15 — — EP disclosed
WO-1991004738-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-04-18 — — WO disclosed
US-4959485-A 5-HT3 ANTAGONISTS RORER PHARMACEUTICAL CORPORATION (US) 1990-09-25 — — US disclosed
WO-1989010364-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-11-02 — — WO disclosed
EP-0339950-A2 Dibenzofurancarboxamides, their use as pharmaceutical agents, a composition containing the same, and a process for the preparation thereof RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-11-02 — — EP disclosed
US-4863921-A Dibenzofurancarboxamides and their pharmaceutical compositions and methods RORER PHARMACEUTICAL CORPORATION (US) 1989-09-05 — — US disclosed
Send feedback